Literature DB >> 7880738

Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.

G Krosl1, M Korbelik, G J Dougherty.   

Abstract

Cellular populations in the squamous cell carcinoma SCCVII, growing in C3H/HeN mice given Photofrin, were examined at various time intervals during the photodynamic light treatment and up to 8 h later. Cell populations present within excised tumours were identified by monoclonal antibodies directed against cell type-specific membrane markers using a combination of the indirect immunoperoxidase and Wright staining or by flow cytometry. Photofrin-based photodynamic therapy (PDT) induced dramatic changes in the level of different cellular populations contained in the treated tumour. The most pronounced was a rapid increase in the content of neutrophils, which increased 200-fold within 5 min after the initiation of light treatment. This was followed immediately by an increase in the levels of mast cells, while another type of myeloid cells, most likely monocytes, invaded the tumour between 0 and 2 h after PDT. The examination of cytolysis of in vitro cultured SCCVII tumour cells mediated by macrophages harvested from the SCCVII tumour revealed a pronounced increase in the tumoricidal activity of tumour-associated macrophages isolated at 2 h post PDT. It seems, therefore, that the PDT-induced acute inflammatory infiltration of myeloid cells into the treated tumour is associated with functional activation of immune cells.

Entities:  

Mesh:

Year:  1995        PMID: 7880738      PMCID: PMC2033617          DOI: 10.1038/bjc.1995.108

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Modulation of hematoporphyrin derivative-sensitized phototherapy with corynebacterium parvum in murine transitional cell carcinoma.

Authors:  R C Myers; B H Lau; D Y Kunihira; R R Torrey; J L Woolley; J Tosk
Journal:  Urology       Date:  1989-03       Impact factor: 2.649

2.  Identification and characterization of 114/A10, an antigen highly expressed on the surface of murine myeloid and erythroid progenitor cells and IL-3-dependent cell lines.

Authors:  G J Dougherty; S T Dougherty; R J Kay; P Landsdorp; R K Humphries
Journal:  Exp Hematol       Date:  1989-09       Impact factor: 3.084

3.  Release of prostaglandin E2 from cells by photodynamic treatment in vitro.

Authors:  B W Henderson; J M Donovan
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

4.  Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages.

Authors:  D H Lynch; S Haddad; V J King; M J Ott; R C Straight; C J Jolles
Journal:  Photochem Photobiol       Date:  1989-04       Impact factor: 3.421

5.  Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.

Authors:  N Yamamoto; D A St Claire; S Homma; B Z Ngwenya
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

6.  Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages.

Authors:  B Z Ngwenya; N Yamamoto
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids.

Authors:  N Yamamoto; B Z Ngwenya
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

8.  Singlet oxygen intermediacy in the photodynamic action of membrane-bound hematoporphyrin derivative.

Authors:  J P Thomas; R D Hall; A W Girotti
Journal:  Cancer Lett       Date:  1987-06       Impact factor: 8.679

9.  Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha.

Authors:  D A Bellnier
Journal:  J Photochem Photobiol B       Date:  1991-01       Impact factor: 6.252

10.  Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours.

Authors:  P L Olive; D J Chaplin; R E Durand
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

View more
  45 in total

1.  Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.

Authors:  Eleonora Reginato; Peter Wolf; Michael R Hamblin
Journal:  World J Immunol       Date:  2014-03-27

Review 2.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

3.  T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

Authors:  Florian Anzengruber; Pinar Avci; Lucas Freitas de Freitas; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-06-11       Impact factor: 3.982

Review 4.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

5.  Intratumor administration of the photosensitizer pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals.

Authors:  Thomas H Foster; Benjamin R Giesselman; Rui Hu; Malcolm E Kenney; Soumya Mitra
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

6.  Pheophorbide a-Mediated Photodynamic Therapy Triggers HLA Class I-Restricted Antigen Presentation in Human Hepatocellular Carcinoma.

Authors:  Patrick Ming-Kuen Tang; Ngoc-Ha Bui-Xuan; Chun-Kwok Wong; Wing-Ping Fong; Kwok-Pui Fung
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

7.  The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy.

Authors:  Mladen Korbelik; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-01-26       Impact factor: 3.982

Review 8.  Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.

Authors:  Lorenzo Galluzzi; Juliette Humeau; Aitziber Buqué; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Clin Oncol       Date:  2020-08-05       Impact factor: 66.675

9.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

Authors:  Sulbha K Sharma; Pawel Mroz; Tianhong Dai; Ying-Ying Huang; Tyler G St Denis; Michael R Hamblin
Journal:  Isr J Chem       Date:  2012-09       Impact factor: 3.333

Review 10.  Photodynamic therapy induces an immune response against a bacterial pathogen.

Authors:  Ying-Ying Huang; Masamitsu Tanaka; Daniela Vecchio; Maria Garcia-Diaz; Julie Chang; Yuji Morimoto; Michael R Hamblin
Journal:  Expert Rev Clin Immunol       Date:  2012-07       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.